BC
Bicara Therapeutics Inc. Common Stock (BCAX)
NASDAQ·Healthcare·Biotechnology
$26.34
-2.03%
Mkt Cap $1.53B
Analyst Ratings
Buy
3
Hold
3
Sell
0
Price Target (10 analysts)
$32.33
Range $18.00 – $42.00
Implied Upside
+22.8%
Consensus $32.33 vs current $26.34